Can senolytic clearance help treat my intervertebral disc degeneration?

Intervertebral disc degeneration (IDD) is a primary cause of low back pain. Current medical treatments for IDD are often palliative, meaning they manage symptoms like pain but do not reverse the underlying cellular damage or structural changes in the disc ⁴⁶.

What the research says

Research suggests that the degradation of the intervertebral disc is driven by a cycle of cellular senescence. Senescent cells are old or damaged cells that stop dividing but remain active in the tissue. These cells produce a "senescence-associated secretory phenotype" (SASP), which includes pro-inflammatory cytokines and enzymes that break down the extracellular matrix, leading to further tissue decay ⁴⁵⁶.

Senolytic clearance is an emerging therapeutic strategy designed to target and eliminate these specific senescent cells ⁴⁵. By removing these cells, researchers hope to break the cycle of inflammation and tissue destruction. Some research proposes a "clear, prime, then seed" roadmap for treatment, which would involve using senolytics to clear out damaged cells before using other methods to repair or regenerate the disc tissue ⁴⁶.

What to ask your doctor

• What are the current standard treatments for my specific type of disc degeneration?
• Are there any emerging therapies, such as senolytics, currently in clinical trials for intervertebral disc issues?
• How does the level of inflammation or cellular activity in my discs affect my long-term outlook?
• What are the goals of my current treatment plan: symptom management or structural repair?